Research Article

Comparative outcomes of ERCP in living donor liver transplant recipients and non-transplant patients: single-center experience

Volume: 9 Number: 2 March 12, 2026
TR EN

Comparative outcomes of ERCP in living donor liver transplant recipients and non-transplant patients: single-center experience

Abstract

Aims: Endoscopic retrograde cholangiopancreatography (ERCP) is the primary modality for managing biliary complications after living donor liver transplantation (LDLT). Despite its widespread use, detailed data on cannulation strategies, technical challenges, and complication patterns in the post-transplant population remain limited. Methods: This retrospective cohort study included 467 patients who underwent ERCP between 2022 and 2025 at a high volume tertiary liver transplant center. The LDLT cohort (n=70) was compared with a control group of non-transplant patients undergoing ERCP for benign biliary indications (n=397). Demographic characteristics, ERCP indications, technical parameters, cannulation methods, and 30-day complication rates were analyzed. Results: LDLT patients were significantly younger than controls (52.5 vs. 64.9 years, p<0.001). Biliary strictures were the predominant indication in the LDLT cohort (84.3%), whereas choledocholithiasis dominated in controls (69.5%). Although overall technical success was high and comparable (91.4% vs. 94.7%), LDLT patients required significantly more adjunctive cannulation techniques and demonstrated longer cannulation times (11.6±5.0 vs. 7.1±2.3 minutes, p<0.001). Pancreatic duct cannulation was more frequent in the LDLT group (25.7% vs. 10.6%, p<0.001), yet post-ERCP pancreatitis remained low (1.4%). Cholangitis (37.1% vs. 4.0%, p<0.001) and ICU admission (18.6% vs. 4.0%, p<0.001) were significantly more common among LDLT recipients, although no cholangitis-related mortality occurred. Conclusion: ERCP after LDLT is highly effective but technically more complex, requiring greater procedural expertise and exhibiting higher infectious complication rates. These findings highlight the need for experienced endoscopists and support further multicenter prospective studies to refine optimal cannulation strategies in transplant recipients.

Keywords

References

  1. Boeva I, Karagyozov PI, Tishkov I. Post-liver transplant biliary complications: current knowledge and therapeutic advances. World J Hepatol. 2021;13(1):66. doi:10.4254/wjh.v13.i1.66
  2. Qian YB, Liu CL, Lo CM, Fan ST. Risk factors for biliary complications after liver transplantation. Arch Surg. 2004;139(10):1101-1105. doi:10. 1001/archsurg.139.10.1101
  3. Girotra M, Soota K, Klair JS, Dang SM, Aduli F. Endoscopic management of post-liver transplant biliary complications. World J Gastrointest Endosc. 2015;7(5):446-459. doi:10.4253/wjge.v7.i5.446
  4. Wojcicki M, Milkiewicz P, Silva M. Biliary tract complications after liver transplantation: a review. Dig Surg. 2008;25(4):245-257. doi:10. 1159/000144653
  5. Magro B, Tacelli M, Mazzola A, Conti F, Celsa C. Biliary complications after liver transplantation: current perspectives and future strategies. Hepatobiliary Surg Nutr. 2021;10(1):76-92. doi:10.21037/hbsn.2019.09.01
  6. Sanna C, Giordanino C, Giono I, et al. Safety and efficacy of endoscopic retrograde cholangiopancreatography in patients with post-liver transplant biliary complications: results of a cohort study with long-term follow-up. Gut Liver. 2011;5(3):328-334. doi:10.5009/gnl.2011.5.3.328
  7. Balderramo D, Bordas JM, Sendino O, et al. Complications after ERCP in liver transplant recipients. Gastrointest Endosc. 2011;74(2):285-294. doi:10.1016/j.gie.2011.04.025
  8. Brindise E, Sanchez A, Sahar N. S0907 ERCP in the liver transplant population: is it safe? ACG. 2020;115:S467. doi:10.14309/01.ajg.0000705676. 71805.17

Details

Primary Language

English

Subjects

Gastroenterology and Hepatology

Journal Section

Research Article

Publication Date

March 12, 2026

Submission Date

December 3, 2025

Acceptance Date

January 17, 2026

Published in Issue

Year 2026 Volume: 9 Number: 2

APA
Baş, B., Küçükdemirci, Ö., & Şahin, H. (2026). Comparative outcomes of ERCP in living donor liver transplant recipients and non-transplant patients: single-center experience. Journal of Health Sciences and Medicine, 9(2), 301-305. https://doi.org/10.32322/jhsm.1835191
AMA
1.Baş B, Küçükdemirci Ö, Şahin H. Comparative outcomes of ERCP in living donor liver transplant recipients and non-transplant patients: single-center experience. J Health Sci Med / JHSM. 2026;9(2):301-305. doi:10.32322/jhsm.1835191
Chicago
Baş, Berk, Ömer Küçükdemirci, and Halil Şahin. 2026. “Comparative Outcomes of ERCP in Living Donor Liver Transplant Recipients and Non-Transplant Patients: Single-Center Experience”. Journal of Health Sciences and Medicine 9 (2): 301-5. https://doi.org/10.32322/jhsm.1835191.
EndNote
Baş B, Küçükdemirci Ö, Şahin H (March 1, 2026) Comparative outcomes of ERCP in living donor liver transplant recipients and non-transplant patients: single-center experience. Journal of Health Sciences and Medicine 9 2 301–305.
IEEE
[1]B. Baş, Ö. Küçükdemirci, and H. Şahin, “Comparative outcomes of ERCP in living donor liver transplant recipients and non-transplant patients: single-center experience”, J Health Sci Med / JHSM, vol. 9, no. 2, pp. 301–305, Mar. 2026, doi: 10.32322/jhsm.1835191.
ISNAD
Baş, Berk - Küçükdemirci, Ömer - Şahin, Halil. “Comparative Outcomes of ERCP in Living Donor Liver Transplant Recipients and Non-Transplant Patients: Single-Center Experience”. Journal of Health Sciences and Medicine 9/2 (March 1, 2026): 301-305. https://doi.org/10.32322/jhsm.1835191.
JAMA
1.Baş B, Küçükdemirci Ö, Şahin H. Comparative outcomes of ERCP in living donor liver transplant recipients and non-transplant patients: single-center experience. J Health Sci Med / JHSM. 2026;9:301–305.
MLA
Baş, Berk, et al. “Comparative Outcomes of ERCP in Living Donor Liver Transplant Recipients and Non-Transplant Patients: Single-Center Experience”. Journal of Health Sciences and Medicine, vol. 9, no. 2, Mar. 2026, pp. 301-5, doi:10.32322/jhsm.1835191.
Vancouver
1.Berk Baş, Ömer Küçükdemirci, Halil Şahin. Comparative outcomes of ERCP in living donor liver transplant recipients and non-transplant patients: single-center experience. J Health Sci Med / JHSM. 2026 Mar. 1;9(2):301-5. doi:10.32322/jhsm.1835191

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912

Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.